Form 4: Oscar Health Director David Plouffe Acquires 8,974 Shares of Class A Common Stock

Director David Plouffe acquired 8,974 shares of Oscar Health's Class A common stock on June 6, 2024, through the vesting of restricted stock units.

Summary

• On June 6, 2024, David Plouffe, a director of Oscar Health, Inc., acquired 8,974 shares of Class A common stock.
• The acquisition was due to the vesting of restricted stock units (RSUs).
• Each RSU represents the right to receive one share of Oscar Health's Class A common stock.
• The RSUs vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, contingent upon continued service.
• Vested RSUs will be settled in shares within 45 days following separation from service, a change in control, death, or disability.
• Following the transaction, Plouffe directly owns 114,512 shares of Oscar Health's Class A common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The acquisition of shares by a director is generally viewed as a positive, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a director.

Key Dates